Back
NICE Ltd. (Israel) Vs. Monopar Therapeutics, Inc. Industry Stock Comparison
Sell
39
NICE
NICE Ltd. (Israel)
Last Price:
$109.28
Seasonality Move:
4.07%
Sell
41
MNPR
Monopar Therapeutics, Inc.
Last Price:
$74.46
Seasonality Move:
36.18%
Sell
39
NICE Ltd. (Israel) (NICE)
is a Sell
Is NICE Ltd. (Israel) a Buy, Sell or Hold?
-
The current NICE Ltd. (Israel) [NICE] share price is $108.92. The Score for NICE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
NICE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Monopar Therapeutics, Inc. (MNPR)
is a Sell
Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Monopar Therapeutics, Inc. [MNPR] share price is $77.05. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NICE Stock Price Chart
What is NICE Ltd. (Israel)'s stock price today?
-
The NICE Ltd. (Israel) share price today is $108.92Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NICE is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics, Inc.'s stock price today?
-
The Monopar Therapeutics, Inc. share price today is $77.05Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight selling pressure.
NICE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.95 | Sell |
| Relative Strength Index (14 RSI): | 42.29 | Sell |
| Chaikin Money Flow: | -297376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.42 | Sell |
| Relative Strength Index (14 RSI): | 44.22 | Sell |
| Chaikin Money Flow: | 2392 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NICE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 107.2 | Buy |
| 20-day SMA: | 109.12 | Sell |
| 50-day SMA: | 123.13 | Sell |
| 200-day SMA: | 146.59 | Sell |
| 8-day EMA: | 107.48 | Buy |
| 20-day EMA: | 110.75 | Sell |
| 50-day EMA: | 120.91 | Sell |
| 200-day EMA: | 144.07 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 77.51 | Sell |
| 20-day SMA: | 81.88 | Sell |
| 50-day SMA: | 84.88 | Sell |
| 200-day SMA: | 51.15 | Buy |
| 8-day EMA: | 78.53 | Sell |
| 20-day EMA: | 80.68 | Sell |
| 50-day EMA: | 78.53 | Sell |
| 200-day EMA: | 55.83 | Buy |
NICE Ltd. (Israel) Earnings Growth & NICE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.21 per share, and a decrease next year of $1.14 per share.
Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.
NICE Ltd. (Israel) Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||